Codexis (CDXS) Change in Inventory (2010 - 2026)
Codexis (CDXS) recorded quarterly Change in Inventory of $183000.0 in Q1 2026, up 255.08% quarter-over-quarter from -$118000.0 in Q4 2025, and up 1116.67% on a YoY basis from $15041.1 in Q1 2025.
Codexis (CDXS) Change in Inventory (2010 - 2026) Analysis & Trends
Codexis' Change in Inventory history runs 17 years deep, the most recent figure standing at $183000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 1116.67% year-over-year to $183000.0; the TTM figure through Mar 2026 stood at $220000.0 (up 133.33% YoY), while the FY2025 annual figure was $19000.0, up 102.14% from the prior year.
- Change in Inventory was $183000.0 for Q1 2026 at Codexis, up from -$118000.0 in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $406000.0 in Q4 2022 to a low of -$304000.0 in Q4 2024.
- Historically, Change in Inventory has averaged $49470.6 across 5 years, with a median of -$9000.0 in 2025.
- The sharpest annual moves came in 2022 and 2026: Change in Inventory tumbled 1457.14% in 2022, then jumped 1116.67% in 2026.
- A 5-year view of Change in Inventory shows it stood at $406000.0 in 2022, then retreated by 6.4% to $380000.0 in 2023, then slumped by 180.0% to -$304000.0 in 2024, then soared by 61.18% to -$118000.0 in 2025, then surged by 255.08% to $183000.0 in 2026.
- The last three Change in Inventory figures came in at $183000.0 (Q1 2026), -$118000.0 (Q4 2025), and -$9000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Codexis | 226.01 Mn | 160.87 Mn | 13.18 Mn | 183,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 183,000.00 |
| Mar 31, 2026 | 183,000.00 |
| Dec 31, 2025 | -118,000.00 |
| Dec 31, 2025 | -118,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | 164,000.00 |
| Jun 30, 2025 | 164,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Mar 31, 2025 | -18,000.00 |
| Dec 31, 2024 | -304,000.00 |
| Dec 31, 2024 | -304,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Sep 30, 2024 | -129,000.00 |
| Jun 30, 2024 | -209,000.00 |
| Jun 30, 2024 | -209,000.00 |
| Mar 31, 2024 | -244,000.00 |
| Mar 31, 2024 | -244,000.00 |
| Dec 31, 2023 | 380,000.00 |
| Dec 31, 2023 | 380,000.00 |